Massage Therapy for Cancer-Related Fatigue
The purpose of this study is to develop methods for studying the effect of bodywork therapy on symptoms of fatigue in patients undergoing cancer chemotherapy.
Procedure: Moderate-intensity and low-intensity bodywork therapy
|Study Design:||Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Parallel Assignment
Masking: Open Label
Primary Purpose: Treatment
|Official Title:||Massage Therapy for Cancer-Related Fatigue|
|Study Start Date:||March 2001|
|Estimated Study Completion Date:||March 2004|
The proposed project is a randomized pilot trial of a Swedish-style massage therapy intervention for the treatment of fatigue in patients who are undergoing cancer chemotherapy. Fatigue is the most common complaint of patients receiving treatment for cancer, but is often difficult to treat and causes a substantial decrement in patients' quality of life. Massage therapy is a non-invasive intervention used in many patients with cancer for symptom control. Prior small studies have suggested some efficacy of bodywork therapies in conditions characterized by fatigue, such as fibromyalgia and chronic fatigue syndrome. Based on these results, massage therapy may provide an important adjunct in ameliorating fatigue and enhancing cancer patients' well being.
The proposed study is a 12-week, randomized, three-arm, parallel-comparison clinical trial comparing the effects of a Swedish-style massage regimen to a sham bodywork control and a usual-care group for fatigue reduction in cancer patents undergoing chemotherapy. Patients with breast, ovarian, prostate, or colo-rectal cancer will be enrolled; the primary outcome measure is a quantitative assessment of fatigue symptoms. This study will determine efficacy, functioning, perceptions of fatigue, and quality of life. This study should provide not only important data on the potential efficacy of massage therapy for the treatment of fatigue, but also advance the methodology for studying CAM interventions for difficult-to-treat symptomatic conditions.
Please refer to this study by its ClinicalTrials.gov identifier: NCT00039793
|United States, California|
|Osher Center for Integrative Medicine|
|San Francisco, California, United States, 94143|
|Principal Investigator:||Andrew Avins, MD, MPH||Osher Center for Integrative Medicine, University of California, San Francisco|
|Investigator:||Shelley Adler, PhD||Osher Center for Integrative Medicine, University of California, San Francisco|
|Investigator:||Michael Patterson, MS||Osher Center for Integrative Medicine, University of California, San Francisco|